Immunitybio Stock Technical Analysis
IBRX Stock | USD 4.91 0.33 6.30% |
As of the 19th of April, Immunitybio retains the Downside Deviation of 7.75, risk adjusted performance of 0.0669, and Market Risk Adjusted Performance of 0.1514. Immunitybio technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Immunitybio, which can be compared to its competitors. Please check out Immunitybio coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if Immunitybio is priced fairly, providing market reflects its last-minute price of 4.91 per share. Given that Immunitybio has jensen alpha of 0.4032, we strongly advise you to confirm Immunitybio's regular market performance to make sure the company can sustain itself at a future point.
Immunitybio Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Immunitybio, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ImmunitybioImmunitybio |
Immunitybio Analyst Consensus
Target Price | Advice | # of Analysts | |
4.5 | Buy | 2 | Odds |
Most Immunitybio analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Immunitybio stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Immunitybio, talking to its executives and customers, or listening to Immunitybio conference calls.
Immunitybio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Immunitybio Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Immunitybio volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Immunitybio Trend Analysis
Use this graph to draw trend lines for Immunitybio. You can use it to identify possible trend reversals for Immunitybio as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Immunitybio price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Immunitybio Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Immunitybio applied against its price change over selected period. The best fit line has a slop of 0.04 , which means Immunitybio will continue generating value for investors. It has 122 observation points and a regression sum of squares at 46.98, which is the sum of squared deviations for the predicted Immunitybio price change compared to its average price change.About Immunitybio Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Immunitybio on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Immunitybio based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Immunitybio price pattern first instead of the macroeconomic environment surrounding Immunitybio. By analyzing Immunitybio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Immunitybio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Immunitybio specific price patterns or momentum indicators. Please read more on our technical analysis page.
2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.14 | 3.04E-4 | 2.73E-4 | 2.6E-4 | Price To Sales Ratio | 2.5K | 8.4K | 4.1K | 3.9K |
Immunitybio April 19, 2024 Technical Indicators
Most technical analysis of Immunitybio help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Immunitybio from various momentum indicators to cycle indicators. When you analyze Immunitybio charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 0.0669 | |||
Market Risk Adjusted Performance | 0.1514 | |||
Mean Deviation | 5.25 | |||
Semi Deviation | 7.47 | |||
Downside Deviation | 7.75 | |||
Coefficient Of Variation | 1071.13 | |||
Standard Deviation | 7.48 | |||
Variance | 55.99 | |||
Information Ratio | 0.0842 | |||
Jensen Alpha | 0.4032 | |||
Total Risk Alpha | (0.02) | |||
Sortino Ratio | 0.0813 | |||
Treynor Ratio | 0.1414 | |||
Maximum Drawdown | 46.63 | |||
Value At Risk | (10.38) | |||
Potential Upside | 10.94 | |||
Downside Variance | 60.11 | |||
Semi Variance | 55.86 | |||
Expected Short fall | (6.11) | |||
Skewness | (1.23) | |||
Kurtosis | 5.83 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunitybio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Immunitybio Stock please use our How to Invest in Immunitybio guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Immunitybio Stock analysis
When running Immunitybio's price analysis, check to measure Immunitybio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunitybio is operating at the current time. Most of Immunitybio's value examination focuses on studying past and present price action to predict the probability of Immunitybio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunitybio's price. Additionally, you may evaluate how the addition of Immunitybio to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Immunitybio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunitybio. If investors know Immunitybio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunitybio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.15) | Revenue Per Share 0.001 | Quarterly Revenue Growth 0.904 | Return On Assets (0.52) |
The market value of Immunitybio is measured differently than its book value, which is the value of Immunitybio that is recorded on the company's balance sheet. Investors also form their own opinion of Immunitybio's value that differs from its market value or its book value, called intrinsic value, which is Immunitybio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunitybio's market value can be influenced by many factors that don't directly affect Immunitybio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunitybio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunitybio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunitybio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.